Medcxy

Product dossierBuilt from registrations, label text and platform-curated data

华熙含盐酸利多卡因注射用交联透明质酸钠凝胶

Ask about this product

华熙 is a Hyaluronic acid filler product (Class III device), registered by 华熙生物科技股份有限公司. Linked registrations: China 国械注准20263131525. First approved in China on 2026-07-28 (国械注准20263131525). Data as of 2026-10-24.

  • Regulatory classHyaluronic acid filler · Class III device
  • Holder华熙生物科技股份有限公司
  • JurisdictionsCN
  • Updated2026-10-24 · v1

Registration and basics are public; findings and prices need an account

Registration and basics

华熙

Product
Regulatory class
Class III device
Category
Hyaluronic acid filler
China · NMPA device registration
国械注准20263131525
Name on registration
含盐酸利多卡因注射用交联透明质酸钠凝胶
Registrant
华熙生物科技股份有限公司
First approval
2026-07-28
This certificate issued
2026-07-28
Valid until
2031-07-27
Models and sizes
0.5 mL:11 mg、0.75 mL:16.5 mg、1.0 mL:22 mg、1.25 mL:27.5 mg、1.5 mL:33 mg、2.0 mL:44 mg
Checked against official page
2026-10-23

Public: fields from the registration record.

Label facts by jurisdiction

What each jurisdiction's label says for the same attribute; gaps are marked Not reported, irrelevant ones N/A

No data yet

Registration timeline

  1. CN

    国械注准20263131525 first approved

  2. CN

    国械注准20263131525 change

    首次获批（受理号 CQZ2402341；2026年07月29日医疗器械批准证明文件送达信息）

  3. CN

    国械注准20263131525 valid until

First approval, this certificate's issue date (updated after renewals or changes), changes and expiry are listed separately; a missing first approval means it was not obtained from an official source. Up to 6 recent changes per registration; click the number for the full record.

Cross findings · Price observations

Sign in to see findings and prices

Findings and prices stay out of indexable pages.

Sign in to view

Recent changes

1
  • 国械注准20263131525: 首次获批（受理号 CQZ2402341；2026年07月29日医疗器械批准证明文件送达信息）2026-07-28

Sources

1